bpc-157 mechanism of action tendon healing High-level overview pathways modulated by BPC-157. It is important Therapeutic and Bioactive Peptides in

CUTTING-EDGE 4-LAYER MATRIX TECHNOLOGY Advanced multi-layer design controls a steady 24-hour release of GHK-Cu copper peptides for efficient absorption and minimal waste

Side Effects and Safety# Epitalon Safety Profile# Preclinical record: No significant adverse effects across decades of animal studies Injection site effects: Mild redness and transient discomfort at injection sites Cancer concern: Telomerase activation theoretically risks promoting pre-cancerous cells, though Epitalon studies showed reduced rather than increased tumor incidence Limitation: Safety data predominantly from a single research group without large-scale, independent safety assessments NAD+ Safety Profile# Human trial data: NMN (250-1200 mg/day) and NR (300-2000 mg/day) have shown favorable safety in multiple human studies lasting weeks to months Common effects: Mild GI symptoms (nausea, bloating) at higher doses

Toxicity of Biologically Active Peptides and Future Safety Aspects: An Update

Most published Epithalon research has involved injectable formulations